Nonoperative Management of Technically Resectable Pancreatic Cancer With Ablative Radiation Therapy

医学 放射治疗 胰腺癌 累积发病率 离格 队列 癌症 内科学 腺癌 外科 肿瘤科
作者
Marsha Reyngold,Joshua D. Schoenfeld,Eileen M. O’Reilly,Anna M. Varghese,Charlie White,Melissa Zinovoy,Paul B. Romesser,Abraham J. Wu,Carla Hajj,John Cuaron,Danny N. Khalil,Wungki Park,Wei Lü,Zhigang Zhang,Kenneth H. Yu,Luis A. Díaz,Christopher H. Crane
出处
期刊:JAMA Oncology [American Medical Association]
标识
DOI:10.1001/jamaoncol.2025.0460
摘要

Importance Surgical resection of pancreatic ductal adenocarcinoma (PDAC) modestly improves long-term survival due to the competing risk of metastatic disease. However, postoperative morbidity often interferes with administration of systemic therapy and may be unacceptable to some patients. Ablative radiation therapy (A-RT) has emerged as an effective noninvasive local treatment in many tumor types and may provide an alternative to surgery in select patients with resectable PDAC. Objective To estimate the efficacy of A-RT in technically resectable PDAC. Design, Setting, and Participants This cohort study of consecutive patients with histologically confirmed, radiographically resectable T1-2N0-1M0 PDAC treated with A-RT at Memorial Sloan Kettering Cancer Center between June 2016 and December 2022 were included from a prospectively maintained database. Patients were not eligible for surgery because of noncancer-related comorbidities. Data were frozen for analysis in December 2023, which took place between March and November 2024. Exposures All patients received A-RT exceeding 97.5-Gy biologically effective dose with daily computed tomography or magnetic resonance imaging guidance, motion management, and daily or selective adaptation of the dose distribution. Main Outcomes and Measures The primary outcome was overall survival (OS). Secondary outcomes included biochemical and radiographic objective response rate, cumulative incidence of local progression, progression-free survival, and distant metastasis–free survival. Results Of 25 patients with radiographically resectable PDAC who received A-RT, 13 (52%) were male, and the median (IQR) age at time of A-RT was 80 (74-87) years. A total of 20 patients (80%) had a Karnofsky Performance Status score of 80 or lower. A total of 15 tumors (60%) were T2, and 4 (16%) were node positive. A total of 17 patients (68%) received induction chemotherapy for a median (range) of 2.9 (1.0-6.1) months. Radiation therapy regimens delivered with conventional linear accelerators included 75 Gy in 25 fractions among 13 patients, 67.5 Gy in 15 fractions among 9 patients, 50 Gy in 5 fractions among 2 patients (magnetic resonance imaging-guided linear accelerator), and 60 Gy in 10 for 1 patient. OS, local progression, and distant metastasis–free survival at 2 years were 43.7% (95% CI, 27.4%-69.5%), 20.8% (95% CI, 7.3%-39.0%), and 20.0% (95% CI, 9.1%-43.8%), respectively. Grade 3 acute and late gastrointestinal tract toxic effects were noted in 3 and 1 patients, respectively, with no grade 4 or higher events. Conclusions and Relevance In this cohort study, A-RT in patients with technically resectable PDAC led to effective local tumor control and favorable OS despite advanced age, poor Karnofsky Performance Status score, and conservative use of chemotherapy in the cohort studied. These data support a prospective study of A-RT for the management of resectable PDAC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
3秒前
5秒前
007完成签到 ,获得积分10
5秒前
善良的冰颜完成签到 ,获得积分10
8秒前
危机的冷风完成签到,获得积分20
8秒前
JETSTREAM完成签到,获得积分10
8秒前
甜美无剑发布了新的文献求助10
9秒前
大气亦巧发布了新的文献求助30
12秒前
ZHou完成签到,获得积分10
13秒前
天上白玉京完成签到,获得积分10
14秒前
14秒前
透明人完成签到,获得积分10
14秒前
17秒前
18秒前
20秒前
科研通AI5应助ZHou采纳,获得10
20秒前
22秒前
26秒前
今夕是何年完成签到 ,获得积分10
26秒前
万能图书馆应助欧凰采纳,获得30
27秒前
我是老大应助balabala采纳,获得10
28秒前
31秒前
大气亦巧完成签到,获得积分10
31秒前
33秒前
35秒前
35秒前
36秒前
霸气的思柔完成签到,获得积分10
38秒前
39秒前
渊澄完成签到 ,获得积分10
39秒前
40秒前
balabala发布了新的文献求助10
40秒前
自觉的向日葵完成签到,获得积分10
40秒前
Jasper应助Nia采纳,获得10
40秒前
42秒前
蓝莓酱蘸橘子完成签到 ,获得积分10
42秒前
不知道发布了新的文献求助10
43秒前
CJ完成签到,获得积分10
44秒前
shushu发布了新的文献求助10
46秒前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
Continuum Thermodynamics and Material Modelling 2000
Encyclopedia of Geology (2nd Edition) 2000
105th Edition CRC Handbook of Chemistry and Physics 1600
Maneuvering of a Damaged Navy Combatant 650
Периодизация спортивной тренировки. Общая теория и её практическое применение 310
Mixing the elements of mass customisation 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3778778
求助须知:如何正确求助?哪些是违规求助? 3324341
关于积分的说明 10217992
捐赠科研通 3039436
什么是DOI,文献DOI怎么找? 1668089
邀请新用户注册赠送积分活动 798545
科研通“疑难数据库(出版商)”最低求助积分说明 758415